Takaaki Yokota

Randomized Phase III and Extension Studies of Naldemedine in Patients With Opioid-Induced Constipation and Cancer

Nobuyuki Katakami, Toshiyuki Harada, Tōru Murata et al. · Journal of Clinical Oncology · 2017 · 139 citations

Medicine, Pharmacology, Pharmacotherapy +17

Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients With Cancer

Nobuyuki Katakami, Koji Oda, Katsunori Tauchi et al. · Journal of Clinical Oncology · 2017 · 64 citations

Nursing, Pharmacology, Pharmacotherapy +17

Randomized phase III and extension studies: efficacy and impacts on quality of life of naldemedine in subjects with opioid-induced constipation and cancer

Nobuyuki Katakami, Toshiyuki Harada, T. Murata et al. · Annals of Oncology · 2018 · 52 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Safety and efficacy of naldemedine in cancer patients with opioid-induced constipation: a pooled, subgroup analysis of two randomised controlled studies

Iwao Osaka, Hiroto Ishiki, Takaaki Yokota et al. · ESMO Open · 2019 · 31 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Naldemedine in Japanese patients with opioid-induced constipation and chronic noncancer pain: open-label Phase III studies

Yoji Saito, Takaaki Yokota, Masatsugu Arai et al. · Journal of Pain Research · 2018 · 27 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17